1. The omicron BA.1-adapted BNT162b2 vaccine candidates elicited significant neutralizing antibodies against the omicron strains as well as the ancestral...
1. A dominant deep-intron GAA repeat expansion in the FGF14 gene was found among French Canadian patients with late-onset cerebellar...
1. A hospital-based strategy to support clinical decision-making and rapid follow-up resulted in a lower risk of death and hospitalization...
1. In intensive care unit (ICU) patients with delirium, haloperidol treatment did not improve the number of days alive and...
1. Topical gene therapy beremagene geperpavec (B-VEC) was superior to placebo in achieving complete wound healing in patients with dystrophic...
1. Within the Adaptive COVID-19 Treatment Trial (ACCT) series, improvement in standard of care (SOC) alone contributed to better recovery...
1. The current cohort study found that buprenorphine for treating opioid use disorder during pregnancy was associated with lower neonatal...
1. In patients with type 2 diabetes and hypertriglyceridemia, pemafibrate did not alter the incidence of cardiovascular events compared to placebo....
1. The monoclonal antibody CIS43LS was associated with dose-dependent protection against malaria infection in adults in Mali. 2. CIS43LS had...
1. Early mobilization of patients after mechanical ventilation in the intensive care unit (ICU) did not result in an improvement...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.